Published in J Invest Dermatol on June 01, 2005
The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea. Indian J Dermatol (2010) 0.86
Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects. Indian J Dermatol (2016) 0.86
Childhood Pityriasis rosea inversa without Herald Patch Mimicking Cutaneous Mastocytosis. Iran J Pediatr (2010) 0.81
Applicability of proposed diagnostic criteria of pityriasis rosea: results of a prospective case-control study in India. Indian J Dermatol (2013) 0.79
Pityriasis rosea like drug rash - a need to identify the disease in childhood. J Clin Diagn Res (2014) 0.78
A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea. J Clin Diagn Res (2014) 0.77
Human herpesviruses 6, 7, and 8 from a dermatologic perspective. Mayo Clin Proc (2012) 0.77
Pityriasis rosea in pregnancy: report of a spousal occurrence and craniosynostosis in the healthy newborn. Dermatol Pract Concept (2016) 0.75
Pityriasis rosea in chronic hepatitis C. Balkan Med J (2014) 0.75
Is a treatment for pityriasis rosea really needed? Indian Dermatol Online J (2016) 0.75
Red Cell Distribution Width and Mean Platelet Volume in Patients With Pityriasis Rosea. J Clin Med Res (2016) 0.75
The Role of Cytokines, Chemokines, and Growth Factors in the Pathogenesis of Pityriasis Rosea. Mediators Inflamm (2015) 0.75
Dermatology for the allergist. World Allergy Organ J (2010) 0.75
Higher Expression of Toll-like Receptors 3, 7, 8, and 9 in Pityriasis Rosea. J Pathol Transl Med (2017) 0.75
Clinical variants of pityriasis rosea. World J Clin Cases (2017) 0.75
A fatal case of DRESS induced by strontium ranelate associated with HHV-7 reactivation. Osteoporos Int (2015) 0.75
Possibility that transmissible viruses might be involved in the etiology of human cancer. Rev Clin Exp Hematol (2003) 3.76
International network for comparison of HIV neutralization assays: the NeutNet report. PLoS One (2009) 2.03
A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma. Cancer Prev Res (Phila) (2012) 2.02
Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes. Nat Biotechnol (2002) 1.95
Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. Am J Physiol Heart Circ Physiol (2010) 1.70
A relapsing inflammatory syndrome and active human herpesvirus 8 infection. N Engl J Med (2005) 1.63
A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load. Nat Protoc (2008) 1.60
Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol (2008) 1.59
Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol (2011) 1.50
Rapid diagnosis of mycobacterial infections and quantitation of Mycobacterium tuberculosis load by two real-time calibrated PCR assays. J Clin Microbiol (2003) 1.46
Recognition of RANTES by extracellular parts of the CCR5 receptor. J Mol Biol (2006) 1.35
Classification of HHV-6A and HHV-6B as distinct viruses. Arch Virol (2013) 1.33
Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids. J Clin Microbiol (2002) 1.32
Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J Virol (2003) 1.25
Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. Blood (2007) 1.16
Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer. Proc Natl Acad Sci U S A (2011) 1.16
Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46. J Biol Chem (2003) 1.16
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein. J Mol Biol (2008) 1.14
IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. Blood (2012) 1.14
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals. Proc Natl Acad Sci U S A (2007) 1.12
The efficacy of macrolides and acyclovir in pityriasis rosea. Indian J Dermatol Venereol Leprol (2015) 1.08
Bortezomib induces autophagic death in proliferating human endothelial cells. Exp Cell Res (2009) 1.08
Expression of CD4 on human peripheral blood neutrophils. Blood (2003) 1.07
Clinical significance of HIV-1 coreceptor usage. J Transl Med (2011) 1.07
Chemokines as natural HIV antagonists. Curr Mol Med (2002) 1.05
Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. Am J Cardiol (2009) 1.04
Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation. J Virol (2006) 1.04
Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib. Blood (2006) 1.04
Selective suppression of IL-12 production by human herpesvirus 6. Blood (2003) 1.03
Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum. J Clin Microbiol (2008) 1.01
Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function. J Biol Chem (2002) 0.99
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers. Antimicrob Agents Chemother (2010) 0.99
Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage. FASEB J (2004) 0.99
Rational design of novel HIV-1 entry inhibitors by RANTES engineering. Vaccine (2008) 0.99
Human herpesvirus 6A accelerates AIDS progression in macaques. Proc Natl Acad Sci U S A (2007) 0.98
The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration. FASEB J (2007) 0.97
Inhibition of CXCR4-tropic HIV-1 infection by lipopolysaccharide: evidence of different mechanisms in macrophages and T lymphocytes. J Immunol (2002) 0.95
Pemphigus improving with gluten-free diet. Acta Derm Venereol (2005) 0.95
Medallion-like dermal dendrocyte hamartoma: a case misdiagnosed as neurofibroma. Pediatr Dermatol (2010) 0.93
Cutaneous immunologic reactions to hepatitis B virus vaccine. Ann Intern Med (2002) 0.93
R5 HIV-1 envelope attracts dendritic cells to cross the human intestinal epithelium and sample luminal virions via engagement of the CCR5. EMBO Mol Med (2013) 0.93
Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance. Clin Diagn Lab Immunol (2002) 0.92
Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy. J Med Virol (2009) 0.92
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor. Proc Natl Acad Sci U S A (2012) 0.91
Automated extraction and quantitation of oncogenic HPV genotypes from cervical samples by a real-time PCR-based system. J Virol Methods (2007) 0.90
Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6. J Virol (2005) 0.90
Pityriasis rosea and herpesviruses: facts and controversies. Clin Dermatol (2010) 0.90
Expansion of T-cell receptor zeta dim effector T cells in acute coronary syndromes. Arterioscler Thromb Vasc Biol (2008) 0.89
P2X7 receptor is expressed in human vessels and might play a role in atherosclerosis. Int J Cardiol (2013) 0.87
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT. AIDS Res Ther (2008) 0.87
Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity. Proc Natl Acad Sci U S A (2014) 0.87
Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models. Cancer Res (2002) 0.86
Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples. J Virol Methods (2013) 0.86
Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques. PLoS Pathog (2012) 0.86
Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study. J Med Virol (2012) 0.86
Preparing for phase II/III HIV vaccine trials in Africa. Microbes Infect (2005) 0.86
Recurrence of hepatitis C virus infection during pityriasis rosea. Acta Derm Venereol (2013) 0.86
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A. Retrovirology (2009) 0.85
Skin manifestations induced by TNF-alpha inhibitors in juvenile idiopathic arthritis. Clin Rev Allergy Immunol (2012) 0.85
Pregnancy outcome in patients with pityriasis rosea. J Am Acad Dermatol (2008) 0.84
Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial. J Gastroenterol (2012) 0.84
Difficult to control atopic dermatitis. World Allergy Organ J (2013) 0.84
Inhibition of chemokine expression in rat inflamed paws by systemic use of the antihyperalgesic oxidized ATP. BMC Immunol (2005) 0.84
Targeting angiogenesis with compounds from the extracellular matrix. Int J Biochem Cell Biol (2011) 0.84
Therapeutic patient education in atopic dermatitis: worldwide experiences. Pediatr Dermatol (2013) 0.84
Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages. Virology (2009) 0.83
Fixed drug eruption due to propranolol. Acta Derm Venereol (2006) 0.83
Difficult treatment of consumptive hypothyroidism in a child with massive parotid hemangioma. J Pediatr Endocrinol Metab (2012) 0.83
Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection. J Transl Med (2009) 0.82
Direct and allosteric inhibition of the FGF2/HSPGs/FGFR1 ternary complex formation by an antiangiogenic, thrombospondin-1-mimic small molecule. PLoS One (2012) 0.82
Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies. Rev Clin Exp Hematol (2003) 0.82
Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity. Biochem Biophys Res Commun (2006) 0.82
Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005. J Allergy Clin Immunol (2006) 0.82
Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients. PLoS One (2012) 0.82
Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae. PLoS One (2012) 0.82
Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides. Chem Biol (2012) 0.81
A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2. J Virol Methods (2011) 0.81
Rosacea treatments: What's new and what's on the horizon? Am J Clin Dermatol (2010) 0.81
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants. Protein Expr Purif (2009) 0.81
Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4. PLoS One (2011) 0.81
Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases. J Med Virol (2013) 0.81
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses. J Immunol Methods (2011) 0.81
Localized severe scleroderma: a retrospective study of 26 pediatric patients. Pediatr Dermatol (2010) 0.80
Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases. J Clin Virol (2009) 0.80
Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting system. Br J Haematol (2002) 0.80
Development of a human herpesvirus 6 species-specific immunoblotting assay. J Clin Microbiol (2012) 0.80
Immunomodulation and immunosuppression by human herpesvirus 6A and 6B. Future Virol (2013) 0.80
Differentiated human neural stem cells: a new ex vivo model to study HHV-6 infection of the central nervous system. J Clin Virol (2006) 0.80